CONTACT INFORMATION

Also presented by Cleveland Clinic: Advanced CV Imaging and Decision Making

Saturday, Nov. 3

Register at: ccfcme.org/cvimaging12

 

 
 
 

Clarifying Controversies in Cardiovascular Outcomes: Evidence Based Strategies for Setting and Achieving Glycemic Goals in Type 2 Diabetes


November 3, 2012

 

The Westin Bonaventure – San Francisco Ballroom
Los Angeles, CA
7:00pm – 9:30pm

 

This event is not part of the official Scientific Session 2012 as planned by the
AHA Committee on Scientific Sessions Programming.

Register Online Today

Print this Content

 

Description

Life expectancy for a patient with Type 2 diabetes is substantially shorter than for one without this disease, largely because of the greater risk of cardiovascular disease associated with diabetes and lesser degrees of dysglycemia.

This activity will address knowledge gaps on interpreting and applying data that support the importance of glycemic control to improve cardiovascular outcomes in patients with Type 2 diabetes. Past and new clinical data will be examined and deciphered to foster appropriate tailoring of therapy to get patients to individual glycemic targets. Key experts will provide insight and guidance on applying these data to clinical practice to optimize glycemic control and improve cardiovascular outcomes.

Back to Top

 

Learning Objectives

1. Identify and evaluate the results of clinical trials that demonstrate the effect of glycemic control on cardiovascular outcomes in patients with T2D

2. Translate clinical trial data into practical, individualized strategies to establish and achieve glycemic goals in patients with T2D

3. Apply clinical evidence and guideline to determine which patients would benefit from aggressive glucose management

4. Intensify therapy in patients with uncontrolled hyperglycemia, considering patient characteristics and desires

5. Expand the role of the cardiologist in aggressive management of hyperglycemia with the goal of preventing CVD

Back to Top

 

Target Audience

Clinical Cardiologists, Endocrinologists, Internal Medicine Physicians, Nurses/Nurse Practitioners, Physician Assistants.

Back to Top

 

Course Directors

Steven Nissen, MD
Professor of Medicine
Chairman, Tomisch Department of Cardiovascular Medicine
Heart and Vascular Institute
Cleveland Clinic
Cleveland, OH


Katherine J. Hoercher, RN
Senior Director of Special Programs
Kaufman Center for Heart Failure
Heart and Vascular Institute
Cleveland Clinic
Cleveland, OH

Back to Top

 

Faculty

Leslie Cho, MD
Cleveland Clinic
Cleveland, OH

William C. Cushman, MD
Memphis VA Medical Center
Memphis, TN

Robert H. Eckel, MD
University of Colorado Anschutz Medical Campus
Aurora, CO

Lawrence A. Leiter, MD, FRCPC, FACP
St. Michael's Hospital, University of Toronto
Toronto, Ont.
Canada

Back to Top

 

Agenda

Saturday, November 3, 2012
7:00 pm Buffet Dinner
Moderator: Steven Nissen, MD

7:30  pm Welcome and Audience - Pre-Assessment (ARS System)

7:40 pm The Critical Intersection of Diabetes and Cardiovascular Disease
Leslie Cho, MD

7:55 pm How Do We Interpret Previous Studies on Glycemic Control and Cardiovascular Outcomes?
William C. Cushman, MD

8:15 pm What is the Optimal Timing for Initiation of Insulin Therapy in Type 2 Diabetes?                                  Robert H. Eckel, MD
8:35 pm What is the Potential for Current and Emerging Therapies to Improve Cardiovascular Outcomes?
Lawrence A. Leiter, MD

8:55 pm Panel Discussion and Post Assessment with ARS  

9:30 pm Adjourn

Back to Top

 

Location

The Westin Bonaventure – San Francisco Ballroom
Los Angeles, CA
7:00pm – 9:30pm

Back to Top

 

Accreditation

The Cleveland Clinic Foundation Center for Continuing Education is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

The Cleveland Clinic Foundation Center for Continuing Education designates this live activity for a maximum of 2.0 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Participants claiming CME credit from this activity may submit the credit hours to the American Osteopathic Association Council on Continuing Medical Education for Category 2 credit.

Back to Top

 

Americans with Disabilities Act

The Cleveland Clinic Foundation Center for Continuing Education fully intends to comply with the legal requirements of the Americans with Disabilities Act. If you need assistance, please notify Jamie Belkin at 216.932.3448 at least two weeks prior to the activity.

Back to Top

 

Grantors

The Cleveland Clinic Foundation Center for Continuing Education acknowledges an educational grant for support of this activity from: sanofi-aventis U.S.

Back to Top

 

Faculty Disclosure

The Cleveland Clinic Foundation Center for Continuing Medical Education has implemented a policy to comply with the current Accreditation Council for Continuing Medical Education Standards for Commercial Support requiring resolution of all faculty conflicts of interest. Faculty declaring a relevant commercial interest will be identified in the activity syllabus.

For further information or online registration assistance, please contact Jamie Belkin at 216.932.3448 or jamie@jamiebelkin.com.

 

Register Online Today
 

 
Category Guest
Attendee Complimentary

 

Register Online Today

Back to Top

 

 
Bookmark this Chapter
Copyright © 2000-2014 The Cleveland Clinic Foundation. All Rights Reserved.
Center for Continuing Education | 9500 Euclid Avenue, KK31, Cleveland, OH 44195
Copyright © 2000-2014 The Cleveland Clinic Foundation. All Rights Reserved.
Center for Continuing Education | 9500 Euclid Avenue, KK31, Cleveland, OH 44195